Pharmaceutical exports from South Korea increased by 16.7% in 1994 compared with 1993 to their highest-ever level of $411 million, reports Pharma Japan, although sales of finished drug products declined.
The biggest contribution to the overall increase was in exports of bulk pharmaceuticals, which advanced 23.5% to $304.3 million, while overseas sales of cosmetics increased 36.7% to $25 million. However, exports of finished products declined 2.4% to a total of $63.8 million, while traditional medicines were down 20.4% to $14.7 million and exports of sanitary supplies fell 9.1% to $3.3 million.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze